Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System
Int. Journal of Clinical Pharmacology and Therapeutics · 01.03.2026 · 64 (03) · 103-114
DOI: 10.5414/cp204897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.03.2026. Verfasst von Dongnan Cao und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antifungal Agents, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Cao, D., Wei, C., Yuan, Y., & Wu, B. (2026). Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System. Int. Journal of Clinical Pharmacology and Therapeutics, 64(03), 103-114. https://doi.org/10.5414/cp204897
Vancouver
Cao D, Wei C, Yuan Y, Wu B. Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(03):103-114. doi:10.5414/cp204897
BibTeX
@article{Cao2026,
author = {Cao, Dongnan and Wei, Chunyan and Yuan, Yanling and Wu, Bin},
title = {Cardiotoxicity associated with antifungal agents: A pharmacovigilance analysis of the FDA Adverse Event Reporting System},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {03},
pages = {103--114},
doi = {10.5414/cp204897}
}
EUVIMED